MedPath

Sleep Study in Adult Patients With Major Sickle Cell Disease With Paroxysmal Nocturnal Events

Not Applicable
Completed
Conditions
Sickle Cell Disease
Interventions
Other: Polysomnography and blood sample
Registration Number
NCT02539771
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Brief Summary

Hypothesis is that the occurrence of nocturnal Vaso-Occlusive Crisis (VOC) and priapism in adults might be related to episodes of nocturnal desaturation secondary to a sleep apnea syndrome. Investigator hypothesize that chronic biological consequences of Obstructive Sleep Apnea (hypercoagulability, endothelial dysfunction ...) favour VOC and acute manifestations (nocturnal desaturation) favour nocturnal VOC.

The confirmation of this hypothesis will lead investigator to propose a systematic screening of obstructive sleep apnea (OSA) in patients with nocturnal VOC. Moreover, systematic treatment of OSA in sickle cell patients could help significantly reduce the number and severity of nocturnal VOC.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
114
Inclusion Criteria

Night VOC Group:

  • night VOC ≥ 2 in the previous year
  • written informed consent

Daytime VOC Group:

  • VOC no nocturnal
  • diurnal VOC ≥ 2 in the previous year
  • written informed consent

Slightly symptomatic group:

  • no hospitalization for VOC
  • written informed consent
Exclusion Criteria
  • Taking opioids
  • Taking medication that alters sleep (antidepressants, benzodiazepines ...)
  • Known history of sleep apnea syndrome
  • Known history of serious psychiatric disorder
  • Recent vaso-occlusive crisis (within 3 weeks)
  • Changes in background treatment (Hydrea or exchange transfusions) in the past 12 months
  • Inactive affiliation to social security
  • Under legal protection
  • A female who is pregnant or breastfeeding
  • Prisoners
  • Emergency situation
  • Refusing to participate in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Nocturnal VOCPolysomnography and blood sample-
Diurnal VOCPolysomnography and blood sample-
Slightly symptomaticPolysomnography and blood sample-
Primary Outcome Measures
NameTimeMethod
Percentage of patients with nocturnal desaturation and patients with OSAat 1 year
Secondary Outcome Measures
NameTimeMethod
Apnea-Hypopnea Indexat 1 year
Oxygen desaturation indexat 1 year
Quantitative analysis of biomarkers in plasma samplesat 1 year
Quantitative analysis of proinflammatory and anti-inflammatory cytokinesat 1 year
Minimum oxygen saturation levelat 1 year
Minimum oxygen saturation level during rapid eye movement (REM) sleep in patients with recurrent priapism and in patients who never presented priapismat 1 year
Sleep time with arterial oxygen saturation less than 90%at 1 year

Trial Locations

Locations (1)

Henri Mondor Hospital

🇫🇷

Creteil, France

© Copyright 2025. All Rights Reserved by MedPath